Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease

Maria Laura Bolognesi, Rita Banzi, Manuela Bartolini, Andrea Cavalli, Andrea Tarozzi, Vincenza Andrisano, Anna Minarini, Michela Rosini, Vincenzo Tumiatti, Christian Bergamini, Romana Fato, Giorgio Lenaz, Patrizia Hrelia, Antonino Cattaneo, Maurizio Recanatini, Carlo Melchiorre

Research output: Contribution to journalArticle

Abstract

One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disease-modifying therapies is the multifactorial nature of its etiopathology. To circumvent this drawback, the use of multi-target-directed ligands (MTDLs) has recently been proposed as a means of simultaneously hitting several targets involved in the development of the AD syndrome. In this paper, a new class of MTDLs based on a polyamine - quinone skeleton, whose lead (memoquin, 2) showed promising properties in preclinical investigations (Cavalli et al. Angew. Chem., Int. Ed. 2007, 46, 3689-3692), is described. 3-29 were tested in vitro against a number of isolated AD-related targets, namely, AChE and BChE, and Aβ aggregation (both AChE-mediated and self-induced). Furthermore, the ability of the compounds to counteract the oxidative stress in a human neuronal-like cellular system (SH-SY5Y cells) was assayed, in both the presence and absence of NQO1, an enzyme able to generate and maintain the reduced form of quinone.

Original languageEnglish
Pages (from-to)4882-4897
Number of pages16
JournalJournal of Medicinal Chemistry
Volume50
Issue number20
DOIs
Publication statusPublished - Oct 20 2007

Fingerprint

Bearings (structural)
Polyamines
Alzheimer Disease
Ligands
Aptitude
Oxidative stress
Skeleton
Oxidative Stress
Agglomeration
benzoquinone
Enzymes

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Bolognesi, M. L., Banzi, R., Bartolini, M., Cavalli, A., Tarozzi, A., Andrisano, V., ... Melchiorre, C. (2007). Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease. Journal of Medicinal Chemistry, 50(20), 4882-4897. https://doi.org/10.1021/jm070559a

Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease. / Bolognesi, Maria Laura; Banzi, Rita; Bartolini, Manuela; Cavalli, Andrea; Tarozzi, Andrea; Andrisano, Vincenza; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Bergamini, Christian; Fato, Romana; Lenaz, Giorgio; Hrelia, Patrizia; Cattaneo, Antonino; Recanatini, Maurizio; Melchiorre, Carlo.

In: Journal of Medicinal Chemistry, Vol. 50, No. 20, 20.10.2007, p. 4882-4897.

Research output: Contribution to journalArticle

Bolognesi, ML, Banzi, R, Bartolini, M, Cavalli, A, Tarozzi, A, Andrisano, V, Minarini, A, Rosini, M, Tumiatti, V, Bergamini, C, Fato, R, Lenaz, G, Hrelia, P, Cattaneo, A, Recanatini, M & Melchiorre, C 2007, 'Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease', Journal of Medicinal Chemistry, vol. 50, no. 20, pp. 4882-4897. https://doi.org/10.1021/jm070559a
Bolognesi, Maria Laura ; Banzi, Rita ; Bartolini, Manuela ; Cavalli, Andrea ; Tarozzi, Andrea ; Andrisano, Vincenza ; Minarini, Anna ; Rosini, Michela ; Tumiatti, Vincenzo ; Bergamini, Christian ; Fato, Romana ; Lenaz, Giorgio ; Hrelia, Patrizia ; Cattaneo, Antonino ; Recanatini, Maurizio ; Melchiorre, Carlo. / Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease. In: Journal of Medicinal Chemistry. 2007 ; Vol. 50, No. 20. pp. 4882-4897.
@article{b6e2a32a631d48b0818d9bcd9e8daad2,
title = "Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease",
abstract = "One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disease-modifying therapies is the multifactorial nature of its etiopathology. To circumvent this drawback, the use of multi-target-directed ligands (MTDLs) has recently been proposed as a means of simultaneously hitting several targets involved in the development of the AD syndrome. In this paper, a new class of MTDLs based on a polyamine - quinone skeleton, whose lead (memoquin, 2) showed promising properties in preclinical investigations (Cavalli et al. Angew. Chem., Int. Ed. 2007, 46, 3689-3692), is described. 3-29 were tested in vitro against a number of isolated AD-related targets, namely, AChE and BChE, and Aβ aggregation (both AChE-mediated and self-induced). Furthermore, the ability of the compounds to counteract the oxidative stress in a human neuronal-like cellular system (SH-SY5Y cells) was assayed, in both the presence and absence of NQO1, an enzyme able to generate and maintain the reduced form of quinone.",
author = "Bolognesi, {Maria Laura} and Rita Banzi and Manuela Bartolini and Andrea Cavalli and Andrea Tarozzi and Vincenza Andrisano and Anna Minarini and Michela Rosini and Vincenzo Tumiatti and Christian Bergamini and Romana Fato and Giorgio Lenaz and Patrizia Hrelia and Antonino Cattaneo and Maurizio Recanatini and Carlo Melchiorre",
year = "2007",
month = "10",
day = "20",
doi = "10.1021/jm070559a",
language = "English",
volume = "50",
pages = "4882--4897",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "20",

}

TY - JOUR

T1 - Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease

AU - Bolognesi, Maria Laura

AU - Banzi, Rita

AU - Bartolini, Manuela

AU - Cavalli, Andrea

AU - Tarozzi, Andrea

AU - Andrisano, Vincenza

AU - Minarini, Anna

AU - Rosini, Michela

AU - Tumiatti, Vincenzo

AU - Bergamini, Christian

AU - Fato, Romana

AU - Lenaz, Giorgio

AU - Hrelia, Patrizia

AU - Cattaneo, Antonino

AU - Recanatini, Maurizio

AU - Melchiorre, Carlo

PY - 2007/10/20

Y1 - 2007/10/20

N2 - One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disease-modifying therapies is the multifactorial nature of its etiopathology. To circumvent this drawback, the use of multi-target-directed ligands (MTDLs) has recently been proposed as a means of simultaneously hitting several targets involved in the development of the AD syndrome. In this paper, a new class of MTDLs based on a polyamine - quinone skeleton, whose lead (memoquin, 2) showed promising properties in preclinical investigations (Cavalli et al. Angew. Chem., Int. Ed. 2007, 46, 3689-3692), is described. 3-29 were tested in vitro against a number of isolated AD-related targets, namely, AChE and BChE, and Aβ aggregation (both AChE-mediated and self-induced). Furthermore, the ability of the compounds to counteract the oxidative stress in a human neuronal-like cellular system (SH-SY5Y cells) was assayed, in both the presence and absence of NQO1, an enzyme able to generate and maintain the reduced form of quinone.

AB - One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disease-modifying therapies is the multifactorial nature of its etiopathology. To circumvent this drawback, the use of multi-target-directed ligands (MTDLs) has recently been proposed as a means of simultaneously hitting several targets involved in the development of the AD syndrome. In this paper, a new class of MTDLs based on a polyamine - quinone skeleton, whose lead (memoquin, 2) showed promising properties in preclinical investigations (Cavalli et al. Angew. Chem., Int. Ed. 2007, 46, 3689-3692), is described. 3-29 were tested in vitro against a number of isolated AD-related targets, namely, AChE and BChE, and Aβ aggregation (both AChE-mediated and self-induced). Furthermore, the ability of the compounds to counteract the oxidative stress in a human neuronal-like cellular system (SH-SY5Y cells) was assayed, in both the presence and absence of NQO1, an enzyme able to generate and maintain the reduced form of quinone.

UR - http://www.scopus.com/inward/record.url?scp=34948904272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34948904272&partnerID=8YFLogxK

U2 - 10.1021/jm070559a

DO - 10.1021/jm070559a

M3 - Article

C2 - 17850125

AN - SCOPUS:34948904272

VL - 50

SP - 4882

EP - 4897

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 20

ER -